Several bioinformatics-based analyses have revealed that increased LYPD7 expression may be implicated in the pathogenesis of NSCLC, while decreased hypermethylation of LYPD DNA is correlated with an invasive phenotype of malignant melanoma [91, 92]. The gene discussed is LYPD6B; the disease is non-small cell lung carcinoma.